Updated clinical overview on cardiac laminopathies: an electrical and mechanical disease

G Peretto1, S Sala1, S Benedetti2

  • 1a Department of Cardiac Electrophysyology and Arrhythmology , IRCCS San Raffaele Hospital and University , Milan , Italy.

Insights

Cardiac laminopathies, caused by LMNA gene mutations, present diverse heart issues. This review synthesizes current knowledge to identify predictors for sudden death and heart failure in mutation carriers.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Cardiac laminopathies result from LMNA gene mutations, leading to varied electrical and mechanical heart abnormalities.
  • Clinical presentations include dilated cardiomyopathy, bradyarrhythmias, and tachyarrhythmias, often in combined phenotypes.

Purpose of the Study:

  • To review and synthesize current evidence on LMNA-associated heart disease.
  • To identify clinical predictors for life-threatening complications like sudden cardiac death and end-stage heart failure.
  • To establish a foundation for future studies aimed at risk stratification in mutation carriers.

Main Methods:

  • Comprehensive literature review of recent evidence on cardiac laminopathies.
  • Analysis of clinical manifestations and outcomes associated with LMNA gene mutations.

Main Results:

  • LMNA gene mutations cause a spectrum of cardiac issues, including arrhythmias and cardiomyopathy.
  • Identifying predictors for sudden cardiac death and heart failure is an ongoing challenge.

Conclusions:

  • Cardiac laminopathies are complex genetic heart diseases requiring further research for effective risk prediction.
  • Future studies should focus on identifying clinically useful predictors to stratify risk in both affected individuals and asymptomatic relatives.

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.2K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.4K
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.5K